Smart-Money SignalNeutral · 50/100— Insider open-market flow is flat over 90 days
Revenue$10.8M
Net Income-$18.4M
EPS$-0.75
Market Cap$241.5M
Price Performance
Historical data including institutional events
Company Profile
M
Michael Amoroso
CEO & Executive Director
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.
